Clinical trial NCT02889510 - References

Type 2 Diabetes — Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus

Citation(s)

•   Davis TM, Knuiman M, Kendall P, Vu H, Davis WA
  Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2000 Oct;50(2):153-9.
•   Davis WA, Knuiman M, Kendall P, Grange V, Davis TM; Fremantle Diabetes Study
  Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2004 Mar;27(3):752-7.
•   Fernández-Real JM, Chico B, Shiratori M, Nara Y, Takahashi H, Ricart W
  Circulating surfactant protein A (SP-A), a marker of lung injury, is associated with insulin resistance. Diabetes Care. 2008 May;31(5):958-63. doi: 10.2337/dc07-2173. Epub 2008 Feb 19.
•   Lecube A, Sampol G, Lloberes P, Romero O, Mesa J, Hernández C, Simó R
  Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study. PLoS One. 2009;4(3):e4692. doi: 10.1371/journal.pone.0004692. Epub 2009 Mar 5.
•   Lecube A, Sampol G, Muñoz X, Hernández C, Mesa J, Simó R
  Type 2 diabetes impairs pulmonary function in morbidly obese women: a case-control study. Diabetologia. 2010 Jun;53(6):1210-6. doi: 10.1007/s00125-010-1700-5. Epub 2010 Mar 9.
•   Lecube A, Sampol G, Muñoz X, Lloberes P, Hernández C, Simó R
  Insulin resistance is related to impaired lung function in morbidly obese women: a case-control study. Diabetes Metab Res Rev. 2010 Nov;26(8):639-45. doi: 10.1002/dmrr.1131. Epub 2010 Sep 29.
•   Mannino DM, Thorn D, Swensen A, Holguin F
  Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008 Oct;32(4):962-9. doi: 10.1183/09031936.00012408. Epub 2008 Jun 25.
•   Nicolaie T, Zavoianu C, Nuta P
  Pulmonary involvement in diabetes mellitus. Rom J Intern Med. 2003;41(4):365-74. Review.
•   Vara E, Arias-Díaz J, Garcia C, Balibrea JL, Blázquez E
  Glucagon-like peptide-1(7-36) amide stimulates surfactant secretion in human type II pneumocytes. Am J Respir Crit Care Med. 2001 Mar;163(4):840-6.
•   Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE, Selvin E, Brancati FL
  Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2008 Apr;31(4):741-6. Epub 2007 Dec 4.

Multicentre Randomized Double Blind, Crossover, Placebo Controlled Clinical Trial to Evaluate the Effect of Liraglutide on Lung Function in Patients With Type 2 Diabetes Mellitus (LIRALUNG Study)

Details for clinical trial NCT02889510